## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.7% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($133.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Levi & Korsinsky Invites Investors to SueWallSt After Molina Healthcare, Inc. Stock Collapse**
- Source: WANE 15 | 20251202T144500 | Neutral | Relevance: 99%
- Levi & Korsinsky is inviting investors who lost money in Molina Healthcare, Inc. stock between February 5, 2025, and July 23, 2025, to join a class action lawsuit. The lawsuit alleges securities fraud and encourages affected investors to contact the firm. Levi & Korsinsky emphasizes its expertise and successful track record in representing shareholders in complex securities litigation.

**2. Molina Healthcare, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MOH**
- Source: FOX 8 News | 20251201T030200 | Neutral | Relevance: 99%
- Molina Healthcare, Inc. is being sued for violations of securities laws, with a class action lawsuit filed against the company (NYSE: MOH). The DJS Law Group is encouraging shareholders who purchased shares between February 5, 2025, and July 23, 2025, to contact them regarding possible lead plaintiff appointments. The lawsuit alleges that Molina made false and misleading statements about a "dislocation between premium rates and medical cost trend" which impacted its 2025 financial guidance.

**3. Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit**
- Source: PR Newswire | 20251201T170000 | Neutral | Relevance: 99%
- Glancy Prongay & Murray LLP has announced a securities fraud class action lawsuit against Molina Healthcare, Inc. (MOH), offering shareholders who incurred losses between February 5, 2025, and July 23, 2025, an opportunity to become lead plaintiffs. The lawsuit alleges that Molina Healthcare failed to disclose material adverse facts regarding its medical cost trend assumptions and financial guidance for fiscal year 2025. Investors are encouraged to contact the firm before the December 2, 2025, deadline to participate.

**4. Investors who lost money on Molina Healthcare, Inc.(MOH) should contact The Gross Law Firm about pending Class Action - MOH**
- Source: Fox 59 | 20251201T134500 | Neutral | Relevance: 99%
- The Gross Law Firm has issued a notice for shareholders of Molina Healthcare, Inc. (NYSE: MOH) who incurred losses during the class period of February 5, 2025, to July 23, 2025. The firm is inviting affected investors to contact them regarding a pending class action lawsuit, alleging that Molina Healthcare made false statements and concealed material adverse facts about its medical cost trend assumptions and financial guidance. Shareholders have until December 2, 2025, to register for this class action to potentially be appointed as a lead plaintiff.

**5. Class Action Filed Against Molina Healthcare, Inc. (MOH) Seeking Recovery for Investors â€“ Contact Levi & Korsinsky**
- Source: GlobeNewswire | 20251201T161300 | Neutral | Relevance: 99%
- Levi & Korsinsky, LLP has filed a class action securities lawsuit against Molina Healthcare, Inc. (NYSE: MOH) on behalf of investors who suffered losses due to alleged securities fraud between February 5, 2025, and July 23, 2025. The lawsuit alleges that Molina made false statements and concealed material facts concerning its medical cost trend assumptions and financial guidance for fiscal year 2025. Investors have until December 2, 2025, to request to be appointed as lead plaintiff.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 38.9% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.7B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -0.62 |
| Forward P/E | 10.4 |
| Current P/E | 10.3 |
| YoY Growth | -0.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 3.3% to -0.7% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.7pp (needs >3.0% for momentum thesis). Below SMA200 (0.61x), long-term trend not supportive. MACD histogram positive (2.32), confirming momentum. RSI neutral at 44.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.71% (CS: 58) | Neutral |
| RSI_14 | 43.9 | Neutral |
| MACD Histogram | 2.32 | Bullish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 0.867x | Below |
| vs SMA200 | 0.611x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $145.97
- **Stop Loss:** $133.91 (8.3% risk)
- **Target:** $158.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 82
- **Position Value:** $11,969.54
- **Portfolio %:** 11.97%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*